Valuation: SMS Pharmaceuticals Limited

Market Cap 39.8B 420M 375M 349M 317M 597M 607M 4.19B 1.64B 20.76B 1.58B 1.54B 66.44B P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 42.99B 454M 405M 377M 342M 644M 656M 4.52B 1.77B 22.43B 1.7B 1.67B 71.77B EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
25.12%
Yield 2025
0.19%
Yield 2026 0.11%
1 day+0.31%
1 week-9.36%
Current month-10.84%
1 month-8.31%
3 months+6.44%
6 months+1.94%
Current year+36.90%
1 week 421.6
Extreme 421.6
454.9
1 month 393.25
Extreme 393.25
494.45
Current year 293.15
Extreme 293.15
494.45
1 year 270.1
Extreme 270.1
494.45
3 years 111.85
Extreme 111.85
494.45
5 years 54.55
Extreme 54.55
494.45
10 years 24
Extreme 24
494.45
Manager TitleAgeSince
Chief Executive Officer 66 29/08/1990
Director of Finance/CFO - 12/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 29/08/1990
Director/Board Member 38 04/06/2020
Director/Board Member 48 28/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-9.36%+55.09%+250.33% 417M
+3.55%+7.01%+51.42%+102.97% 1,077B
-0.25%-1.25%+32.49%+60.78% 612B
+0.59%+4.03%+25.28%+92.49% 501B
-1.48%+1.97%+72.62%+39.42% 364B
+2.37%+5.47%+32.67%+48.87% 353B
+2.64%+4.90%+21.01%+43.85% 278B
+3.24%+4.25%-0.31%+15.71% 251B
+1.86%+6.53%+45.98%+51.29% 230B
+2.49%+6.98%+33.03%+98.70% 190B
Average +1.73%+0.80%+36.93%+80.44% 385.69B
Weighted average by Cap. +1.85%+1.58%+38.51%+70.76%

Financials

2025 2026
Net sales 7.83B 82.64M 73.77M 68.56M 62.36M 117M 119M 824M 322M 4.08B 310M 304M 13.07B 8.89B 93.82M 83.75M 77.83M 70.8M 133M 136M 935M 366M 4.64B 352M 345M 14.84B
Net income 691M 7.3M 6.52M 6.06M 5.51M 10.36M 10.55M 72.74M 28.46M 361M 27.39M 26.81M 1.15B 1.02B 10.77M 9.61M 8.93M 8.13M 15.29M 15.56M 107M 41.98M 532M 40.41M 39.55M 1.7B
Net Debt 2.69B 28.43M 25.38M 23.58M 21.45M 40.36M 41.09M 283M 111M 1.4B 107M 104M 4.5B 3.19B 33.69M 30.07M 27.95M 25.42M 47.83M 48.69M 336M 131M 1.66B 126M 124M 5.33B
Projected Income Statement - Annual - SMS Pharmaceuticals Limited
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
15/10/26 ₹424.95 +0.31% 229,490
14/10/26 ₹423.65 -3.34% 260,472
13/10/26 ₹438.30 -0.70% 386,275
12/10/26 ₹441.40 -0.73% 269,483
09/10/26 ₹444.65 -0.47% 296,160

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SMS Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock